Live Breaking News & Updates on Central Nervous System Tumors

Stay updated with breaking news from Central nervous system tumors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients

Among the 7 patients on VBI-1901 treatment long enough to have 1+ MRI scan at the time of analysis, one partial tumor response and two stable disease observations have occurred as of May 15,. ....

United Kingdom , United States , Prehevbrio Prehevbri , Brii Biosciences , Davide Anderson , Jeff Baxter , Company Quarterly Reports On Form , American Society Of Clinical Oncology , Vaccines Inc , Oncology Center , Drug Administration , Clinical Oncology , Annual Meeting , Scientific Officer , Fast Track , Orphan Drug Designations , Data Poster Highlights , Study Arm , Granulocyte Macrophage Colony Stimulating Factor , Randomized Phase , Central Nervous System Tumors , Patient Enrollment , Study Design , Study Data Highlights , Track Designation , Orphan Drug Designation ,

Pathways Study Genotype Data, Alliance A011502 Sec

New insights on improving clinical outcomes and quality of life among breast cancer patients highlight the slate of new research presentations Roswell Park ....

United States , Mccormick Place , New York , Shipra Gandhi , Rohit Gosain , Manmeet Singh Ahluwalia , Yu Fujiwara , Arya Mariam Roy , Robert Fenstermaker , Eunice Wang , Roswell Park , Renuka Iyer , Solid Tumors Early Phase Clinical Trials Program , National Cancer , American Society Of Clinical Oncology , Miami Cancer Institute , Eunice Wang Co , Roswell Park Comprehensive Cancer Center , Global Oncology Community , Department Of Medicine , Roswell Park Care Network , Gastrointestinal Clinical Disease Team , Quality Care Health Services Research Rapid Oral , Pathways Study , Eunice Wang Co Chairs , American Society ,

TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in Germany

Durable survival effect observed in the largest prospective, non-interventional study completed examining TTFields therapy use in newly diagnosed GBM

Topline data to be presented Saturday, June 1,. ....

New Hampshire , United States , Nicolas Leupin , Exchange Commission , American Society Of Clinical Oncology Annual Meeting , Department Of Neurology , Tumor Treating Fields , General Hospital , Chief Medical , Central Nervous System Tumors , Clinical Oncology Annual Meeting , Treating Fields , Tumor Treating , Annual Report , Private Securities Litigation Reform Act ,

VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients

VBI Vaccines Inc. , a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that new interim tumor response data from the. ....

United States , United Kingdom , Brii Biosciences , Prehevbrio Prehevbri , Drug Administration , Company Quarterly Reports On Form , American Society Of Clinical Oncology , Oncology Center , World Vaccine Congress Washington , Vaccines Inc , Clinical Oncology , Randomized Phase , Central Nervous System Tumors , Session Time , Study Design , Track Designation , Orphan Drug Designation , Accelerated Approval , Priority Review , Drug Evaluation , Biologics Evaluation , Clinical Trial Endpoints , Cancer Drugs , Private Securities Litigation Reform Act , Nasdaq Capital Market , Annual Report ,

Chimeric Therapeutics Ltd begins collaboration with Sarah Cannon Research Institute for glioblastoma clinical trial

Chimeric Therapeutics Ltd (ASX:CHM), the only ASX clinical-stage cell therapy company, welcomes the participation of leading US centre Sarah Cannon Research. ....

United States , Jason Litten , Chimeric Therapeutics Ltd , Sarah Cannon Research Institute , American Society Of Clinical Oncology , Sarah Cannon Transplant , Cellular Therapy Program , South Austin Medical Center , Chimeric Sponsored Phase , American Society , Clinical Oncology , Central Nervous System Tumors ,